141 related articles for article (PubMed ID: 27740890)
1. Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine.
Im MM; Flanagan SA; Ackroyd JJ; Knapp B; Kramer A; Shewach DS
Radiat Res; 2016 Nov; 186(5):466-477. PubMed ID: 27740890
[TBL] [Abstract][Full Text] [Related]
2. Drug metabolism and homologous recombination repair in radiosensitization with gemcitabine.
Im MM; Flanagan SA; Ackroyd JJ; Shewach DS
Radiat Res; 2015 Jan; 183(1):114-23. PubMed ID: 25564718
[TBL] [Abstract][Full Text] [Related]
3. The role of cell cycle progression in radiosensitization by 2',2'-difluoro-2'-deoxycytidine.
Ostruszka LJ; Shewach DS
Cancer Res; 2000 Nov; 60(21):6080-8. PubMed ID: 11085531
[TBL] [Abstract][Full Text] [Related]
4. Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells.
Robinson BW; Im MM; Ljungman M; Praz F; Shewach DS
Cancer Res; 2003 Oct; 63(20):6935-41. PubMed ID: 14583494
[TBL] [Abstract][Full Text] [Related]
5. Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines.
Salem SD; Abou-Tarboush FM; Saeed NM; Al-Qadasi WD; Farah MA; Al-Buhairi M; Al-Harbi N; Alhazza I; Alsbeih G
Gene; 2012 May; 498(2):300-7. PubMed ID: 22353361
[TBL] [Abstract][Full Text] [Related]
6. The role of apoptosis in 2',2'-difluoro-2'-deoxycytidine (gemcitabine)-mediated radiosensitization.
Lawrence TS; Davis MA; Hough A; Rehemtulla A
Clin Cancer Res; 2001 Feb; 7(2):314-9. PubMed ID: 11234886
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitization by gemcitabine in p53 wild-type and mutant MCF-7 breast carcinoma cell lines.
Robinson BW; Shewach DS
Clin Cancer Res; 2001 Aug; 7(8):2581-9. PubMed ID: 11489842
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965
[TBL] [Abstract][Full Text] [Related]
9. Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: a new paradigm for antimetabolite radiosensitizers.
Flanagan SA; Robinson BW; Krokosky CM; Shewach DS
Mol Cancer Ther; 2007 Jun; 6(6):1858-68. PubMed ID: 17575114
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Homologous Recombination and Promotion of Mutagenic Repair of DNA Double-Strand Breaks Underpins Arabinoside-Nucleoside Analogue Radiosensitization.
Magin S; Papaioannou M; Saha J; Staudt C; Iliakis G
Mol Cancer Ther; 2015 Jun; 14(6):1424-33. PubMed ID: 25840584
[TBL] [Abstract][Full Text] [Related]
11. Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2',2'-difluoro-2'-deoxycytidine (Gemcitabine).
Lawrence TS; Chang EY; Hahn TM; Shewach DS
Clin Cancer Res; 1997 May; 3(5):777-82. PubMed ID: 9815749
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.
Morgan MA; Parsels LA; Zhao L; Parsels JD; Davis MA; Hassan MC; Arumugarajah S; Hylander-Gans L; Morosini D; Simeone DM; Canman CE; Normolle DP; Zabludoff SD; Maybaum J; Lawrence TS
Cancer Res; 2010 Jun; 70(12):4972-81. PubMed ID: 20501833
[TBL] [Abstract][Full Text] [Related]
13. Selective targeting of homologous DNA recombination repair by gemcitabine.
Wachters FM; van Putten JW; Maring JG; Zdzienicka MZ; Groen HJ; Kampinga HH
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):553-62. PubMed ID: 12957269
[TBL] [Abstract][Full Text] [Related]
14. The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitization.
Chen M; Hough AM; Lawrence TS
Cancer Chemother Pharmacol; 2000; 45(5):369-74. PubMed ID: 10803919
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells.
Shewach DS; Hahn TM; Chang E; Hertel LW; Lawrence TS
Cancer Res; 1994 Jun; 54(12):3218-23. PubMed ID: 8205542
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine Induces Radiosensitization Through Inhibition of RAD51-dependent Repair for DNA Double-strand Breaks.
Kobashigawa S; Morikawa K; Mori H; Kashino G
Anticancer Res; 2015 May; 35(5):2731-7. PubMed ID: 25964552
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776.
Engelke CG; Parsels LA; Qian Y; Zhang Q; Karnak D; Robertson JR; Tanska DM; Wei D; Davis MA; Parsels JD; Zhao L; Greenson JK; Lawrence TS; Maybaum J; Morgan MA
Clin Cancer Res; 2013 Aug; 19(16):4412-21. PubMed ID: 23804422
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro.
Latz D; Fleckenstein K; Eble M; Blatter J; Wannenmacher M; Weber KJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):875-82. PubMed ID: 9652852
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair.
Kausar T; Schreiber JS; Karnak D; Parsels LA; Parsels JD; Davis MA; Zhao L; Maybaum J; Lawrence TS; Morgan MA
Neoplasia; 2015 Oct; 17(10):757-66. PubMed ID: 26585231
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells.
Ren Q; Kao V; Grem JL
Clin Cancer Res; 1998 Nov; 4(11):2811-8. PubMed ID: 9829747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]